Agoura Podiatry Group Podiatrist - Foot & Ankle Surgery Medicare: Not Enrolled in Medicare Practice Location: 28240 Agoura Rd, Suite101, Agoura Hills, CA 91301 Phone: 818-991-6337 Fax: 818-879-1891 |
Dr. Neil H Steinberg, D.P.M. Podiatrist Medicare: Medicare Enrolled Practice Location: 5925 Bainbridge Ct, Agoura Hills, CA 91301 Phone: 818-889-4774 Fax: 818-889-4814 |
Agoura Los Robles Podiatry Podiatrist - Foot & Ankle Surgery Medicare: Not Enrolled in Medicare Practice Location: 28240 Agoura Rd., Suite 101, Agoura Hills, CA 91301 Phone: 818-707-3668 Fax: 818-707-0622 |
Foot And Ankle Institute Of The West Podiatrist - Foot & Ankle Surgery Medicare: Not Enrolled in Medicare Practice Location: 29525 Canwood St Ste 309, Agoura Hills, CA 91301 Phone: 818-623-5333 Fax: 818-735-0110 |
Dr. Dana Brems, DPM Podiatrist - Foot & Ankle Surgery Medicare: Medicare Enrolled Practice Location: 5115 Clareton Dr Ste 135, Agoura Hills, CA 91301 Phone: 213-373-3246 |
Darren Payne, Dpm, Inc. Podiatrist - Foot & Ankle Surgery Medicare: Not Enrolled in Medicare Practice Location: 28240 Agoura Rd Ste 101, Agoura Hills, CA 91301 Phone: 818-707-3668 Fax: 818-707-0622 |
News Archive
After seven years of a vigorous fight, Jim Hart worried he was running out of options. Diagnosed with prostate cancer at age 60, Hart had undergone virtually every treatment — surgery, radiation and hormones — to eradicate it. But a blood test showed that his level of prostate-specific antigen, which should have been undetectable, kept rising ominously. And doctors couldn't determine where the residual cancer was lurking.
The metabolic syndrome is a public health time bomb. It may affect as many as 1 in 5 adults in some parts of Europe, greatly increasing the risk of developing heart disease and stroke.
Cyntellect, Inc., a privately-held life sciences company commercializing products to advance life science and stem cell research, biopharmaceutical production, and drug discovery, today unveiled its Celigo™ adherent cell cytometry system, the Company's new platform for non-invasive in situ live cell imaging.
Elios Therapeutics, LLC recently received FDA approval of its Investigational New Drug (IND) application and its randomized phase IIb trial planned to enroll 120 stage III and IV (resected) melanoma patients to assess the ability of a personalized vaccine to prevent recurrence.
› Verified 7 days ago